Blue Water Life Science Advisors’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,697,785
| Closed | -$6.11M | – | 8 |
|
|
2025
Q2 | $6.11M | Hold |
4,697,785
| – | – | 4.83% | 8 |
|
|
2025
Q1 | $6.53M | Hold |
4,697,785
| – | – | 6.47% | 5 |
|
|
2024
Q4 | $10.8M | Hold |
4,697,785
| – | – | 9.53% | 5 |
|
|
2024
Q3 | $12.8M | Hold |
4,697,785
| – | – | 11.24% | 4 |
|
|
2024
Q2 | $11M | Hold |
4,697,785
| – | – | 10.69% | 3 |
|
|
2024
Q1 | $22M | Hold |
4,697,785
| – | – | 20.72% | 2 |
|
|
2023
Q4 | $22.9M | Hold |
4,697,785
| – | – | 20.08% | 2 |
|
|
2023
Q3 | $21.8M | Hold |
4,697,785
| – | – | 20.62% | 2 |
|
|
2023
Q2 | $34.7M | Buy |
4,697,785
+2,600,000
| +124% | +$17.4M | 23.43% | 2 |
|
|
2023
Q1 | $17.2M | Buy |
2,097,785
+250,000
| +14% | +$2.61M | 11.35% | 3 |
|
|
2022
Q4 | $17.7M | Sell |
1,847,785
-257,000
| -12% | -$3.16M | 11.88% | 4 |
|
|
2022
Q3 | $24.7M | Hold |
2,104,785
| – | – | 9.98% | 6 |
|
|
2022
Q2 | $27M | Buy |
2,104,785
+16,117
| +0.8% | +$167K | 14.69% | 3 |
|
|
2022
Q1 | $23M | Buy |
2,088,668
+377,861
| +22% | +$4.38M | 10.89% | 5 |
|
|
2021
Q4 | $26.2M | Buy |
+1,710,807
| New | +$22.4M | 8.01% | 7 |
|
Blue Water Life Science Advisors's AKYA Position: Q3 2025 in Review
Blue Water Life Science Advisors sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 4,697,785 shares — an estimated $6.11M sold.
Blue Water Life Science Advisors first reported a position in AKYA in Q4 2021 and held it in 15 quarters. The position peaked at $34.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Blue Water Life Science Advisors reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Blue Water Life Science Advisors sold 4,697,785 Akoya BioSciences shares in Q3 2025, an estimated $6.11M.
- Blue Water Life Science Advisors first reported a position in Akoya BioSciences in Q4 2021 and held it in 15 quarters.
- Blue Water Life Science Advisors's Akoya BioSciences position peaked at $34.7M in Q2 2023.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Blue Water Life Science Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.